- Home
- CCL vs IQV Comparison
CCL vs IQV Comparison
Compare CCL & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCL
- IQV
- Stock Information
- Founded
- CCL 1972
- IQV 1982
- Country
- CCL United States
- IQV United States
- Employees
- CCL N/A
- IQV N/A
- Industry
- CCL Marine Transportation
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CCL Consumer Discretionary
- IQV Health Care
- Exchange
- CCL Nasdaq
- IQV Nasdaq
- Market Cap
- CCL 36.4B
- IQV 36.4B
- IPO Year
- CCL 1987
- IQV 2013
- Fundamental
- Price
- CCL $26.84
- IQV $210.06
- Analyst Decision
- CCL Strong Buy
- IQV Buy
- Analyst Count
- CCL 18
- IQV 18
- Target Price
- CCL $33.22
- IQV $237.89
- AVG Volume (30 Days)
- CCL 22.4M
- IQV 1.8M
- Earning Date
- CCL 12-19-2025
- IQV 10-28-2025
- Dividend Yield
- CCL N/A
- IQV N/A
- EPS Growth
- CCL 61.65
- IQV N/A
- EPS
- CCL 1.94
- IQV 7.30
- Revenue
- CCL $26,230,000,000.00
- IQV $15,904,000,000.00
- Revenue This Year
- CCL $7.65
- IQV $6.14
- Revenue Next Year
- CCL $4.32
- IQV $5.28
- P/E Ratio
- CCL $13.79
- IQV $28.82
- Revenue Growth
- CCL 7.15
- IQV 3.85
- 52 Week Low
- CCL $15.07
- IQV $134.65
- 52 Week High
- CCL $32.80
- IQV $225.91
- Technical
- Relative Strength Index (RSI)
- CCL 39.48
- IQV 53.25
- Support Level
- CCL $25.91
- IQV $207.01
- Resistance Level
- CCL $28.98
- IQV $212.68
- Average True Range (ATR)
- CCL 0.92
- IQV 5.91
- MACD
- CCL -0.21
- IQV -1.58
- Stochastic Oscillator
- CCL 19.84
- IQV 21.88
About CCL Carnival Corporation
Carnival is the largest global cruise company, with more than 90 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.